These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 26549853)

  • 1. ATPergic signalling during seizures and epilepsy.
    Engel T; Alves M; Sheedy C; Henshall DC
    Neuropharmacology; 2016 May; 104():140-53. PubMed ID: 26549853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinergic signalling in brain ischemia.
    Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
    Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and function of the metabotropic purinergic P2Y receptor family in experimental seizure models and patients with drug-refractory epilepsy.
    Alves M; Gomez-Villafuertes R; Delanty N; Farrell MA; O'Brien DF; Miras-Portugal MT; Hernandez MD; Henshall DC; Engel T
    Epilepsia; 2017 Sep; 58(9):1603-1614. PubMed ID: 28733972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purinergic receptors in embryonic and adult neurogenesis.
    Oliveira Á; Illes P; Ulrich H
    Neuropharmacology; 2016 May; 104():272-81. PubMed ID: 26456352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purinergic contribution to amyotrophic lateral sclerosis.
    Volonté C; Apolloni S; Parisi C; Amadio S
    Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal Seizures and Purinergic Signalling.
    Menéndez Méndez A; Smith J; Engel T
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2 receptor signaling in neurons and glial cells of the central nervous system.
    Köles L; Leichsenring A; Rubini P; Illes P
    Adv Pharmacol; 2011; 61():441-93. PubMed ID: 21586367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More than a drug target: Purinergic signalling as a source for diagnostic tools in epilepsy.
    Wong ZW; Engel T
    Neuropharmacology; 2023 Jan; 222():109303. PubMed ID: 36309046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy.
    Alves M; Beamer E; Engel T
    Front Pharmacol; 2018; 9():193. PubMed ID: 29563872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy.
    Engel T; Smith J; Alves M
    J Inflamm Res; 2021; 14():3367-3392. PubMed ID: 34305404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Expression of the Metabotropic P2Y Receptor Family in the Cortex Following Status Epilepticus and Neuroprotection
    Alves M; Smith J; Engel T
    Front Pharmacol; 2019; 10():1558. PubMed ID: 32009961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2X purinoceptors as a link between hyperexcitability and neuroinflammation in status epilepticus.
    Henshall DC; Engel T
    Epilepsy Behav; 2015 Aug; 49():8-12. PubMed ID: 25843343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Context-Specific Switch from Anti- to Pro-epileptogenic Function of the P2Y
    Alves M; De Diego Garcia L; Conte G; Jimenez-Mateos EM; D'Orsi B; Sanz-Rodriguez A; Prehn JHM; Henshall DC; Engel T
    J Neurosci; 2019 Jul; 39(27):5377-5392. PubMed ID: 31048325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing effects of the purinergic P2X7 receptor on seizures in neurons and microglia in male mice.
    Alves M; Gil B; Villegas-Salmerón J; Salari V; Martins-Ferreira R; Arribas Blázquez M; Menéndez Méndez A; Da Rosa Gerbatin R; Smith J; de Diego-Garcia L; Conte G; Sierra-Marquez J; Merino Serrais P; Mitra M; Fernandez Martin A; Wang Y; Kesavan J; Melia C; Parras A; Beamer E; Zimmer B; Heiland M; Cavanagh B; Parcianello Cipolat R; Morgan J; Teng X; Prehn JHM; Fabene PF; Bertini G; Artalejo AR; Ballestar E; Nicke A; Olivos-Oré LA; Connolly NMC; Henshall DC; Engel T
    Brain Behav Immun; 2024 Aug; 120():121-140. PubMed ID: 38777288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice.
    Engel T; Gomez-Villafuertes R; Tanaka K; Mesuret G; Sanz-Rodriguez A; Garcia-Huerta P; Miras-Portugal MT; Henshall DC; Diaz-Hernandez M
    FASEB J; 2012 Apr; 26(4):1616-28. PubMed ID: 22198387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide signalling during inflammation.
    Idzko M; Ferrari D; Eltzschig HK
    Nature; 2014 May; 509(7500):310-7. PubMed ID: 24828189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minor contribution of ATP P2 receptors to electrically-evoked electrographic seizure activity in hippocampal slices: Evidence from purine biosensors and P2 receptor agonists and antagonists.
    Lopatář J; Dale N; Frenguelli BG
    Neuropharmacology; 2011; 61(1-2):25-34. PubMed ID: 21338615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purinergic mechanisms in neuroinflammation: An update from molecules to behavior.
    Beamer E; Gölöncsér F; Horváth G; Bekő K; Otrokocsi L; Koványi B; Sperlágh B
    Neuropharmacology; 2016 May; 104():94-104. PubMed ID: 26384652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of P2 receptors in the growth and survival of neurons in the CNS.
    Franke H; Illes P
    Pharmacol Ther; 2006 Mar; 109(3):297-324. PubMed ID: 16102837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyzing the Role of the P2X7 Receptor in Epilepsy.
    Alves M; de Diego-Garcia L; Engel T
    Methods Mol Biol; 2022; 2510():367-387. PubMed ID: 35776337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.